tetano
Editor, Senior Moderator
Sci Total Environ
. 2020 May 15;734:139278.
doi: 10.1016/j.scitotenv.2020.139278. Online ahead of print.
A Chronicle of SARS-CoV-2: Part-I - Epidemiology, Diagnosis, Prognosis, Transmission and Treatment
Manish Kumar[SUP] 1 [/SUP], Kaling Taki[SUP] 2 [/SUP], Rohit Gahlot[SUP] 3 [/SUP], Ayushi Sharma[SUP] 4 [/SUP], Kiran Dhangar[SUP] 5 [/SUP]
Affiliations
Abstract
In order to benefit the public, community workers and scientific community, we hereby present a chronicle of SARS-CoV-2 that leads to the unseen precedent of social distancing and lockdown owing to coronavirus disease (COVID-19). Information on this life-threatening pandemic of COVID-19 is sparse and discrete; and the urgency is such that the dissemination of information is increasing with numerous daily publications on the topic. Therefore, we developed a comprehensive review on various aspects of SARS-CoV-2 and COVID-19. We scientifically compiled published research, news, and reports from various sources to comprehend and summarize the information and findings on Coronaviruses. The review explicitly covers the aspects like genome and pedigree of SARS-CoV-2; epidemiology, prognosis, pathogenesis, symptoms and diagnosis of COVID-19 in order to catalog the right information on transmission route, and influence of environmental factors on virus transmissions, for the robust understanding of right strategical steps for proper COVID-19 management. We have explicitly highlighted several useful information and facts like: i) No established relationship between progression of SARS-CoV-2 with temperature, humidity and/or both, ii) The underlying mechanism of SARS-CoV-2 is not fully understood, iii) Respiratory droplet size determines drop and airborne-based transmission, iv) Prognosis of COVID-19 can be done by its effects on various body organs, v) Infection can be stopped by restricting the binding of S protein and AE2, vi) Hydroxychloroquine is believed to be better than chloroquine for COVID-19, vii) Ivermectin with Vero-hSLAM cells is able to reduce infection by ~5000 time within 2 days, and viii) Nafamostat mesylate can inhibit SARS-CoV-2 S protein-initiated membrane fusion. We have also suggested future research perspectives, challenges and scope.
Keywords: COVID-19; MERS-CoV; Pathogenesis; SARS-CoV; SARS-CoV-2; Transmission.
. 2020 May 15;734:139278.
doi: 10.1016/j.scitotenv.2020.139278. Online ahead of print.
A Chronicle of SARS-CoV-2: Part-I - Epidemiology, Diagnosis, Prognosis, Transmission and Treatment
Manish Kumar[SUP] 1 [/SUP], Kaling Taki[SUP] 2 [/SUP], Rohit Gahlot[SUP] 3 [/SUP], Ayushi Sharma[SUP] 4 [/SUP], Kiran Dhangar[SUP] 5 [/SUP]
Affiliations
- PMID: 32434058
- DOI: 10.1016/j.scitotenv.2020.139278
Abstract
In order to benefit the public, community workers and scientific community, we hereby present a chronicle of SARS-CoV-2 that leads to the unseen precedent of social distancing and lockdown owing to coronavirus disease (COVID-19). Information on this life-threatening pandemic of COVID-19 is sparse and discrete; and the urgency is such that the dissemination of information is increasing with numerous daily publications on the topic. Therefore, we developed a comprehensive review on various aspects of SARS-CoV-2 and COVID-19. We scientifically compiled published research, news, and reports from various sources to comprehend and summarize the information and findings on Coronaviruses. The review explicitly covers the aspects like genome and pedigree of SARS-CoV-2; epidemiology, prognosis, pathogenesis, symptoms and diagnosis of COVID-19 in order to catalog the right information on transmission route, and influence of environmental factors on virus transmissions, for the robust understanding of right strategical steps for proper COVID-19 management. We have explicitly highlighted several useful information and facts like: i) No established relationship between progression of SARS-CoV-2 with temperature, humidity and/or both, ii) The underlying mechanism of SARS-CoV-2 is not fully understood, iii) Respiratory droplet size determines drop and airborne-based transmission, iv) Prognosis of COVID-19 can be done by its effects on various body organs, v) Infection can be stopped by restricting the binding of S protein and AE2, vi) Hydroxychloroquine is believed to be better than chloroquine for COVID-19, vii) Ivermectin with Vero-hSLAM cells is able to reduce infection by ~5000 time within 2 days, and viii) Nafamostat mesylate can inhibit SARS-CoV-2 S protein-initiated membrane fusion. We have also suggested future research perspectives, challenges and scope.
Keywords: COVID-19; MERS-CoV; Pathogenesis; SARS-CoV; SARS-CoV-2; Transmission.